Author:
Liang Zibin,Wang Siyang,Lin Zhong,Feng Shaoyan,Cheng Zhibin,Yang Yaqi,Kuang Ying,Fidelis Chibhabha,Ullah Shahid,Li Feng
Funder
Guangzhou science and technology research grant
the 111 Project Grant
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference38 articles.
1. Xu J, He X, Cheng K, Guo W, Bian X, Jiang X, Zhang L, Huang S (2014) Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: survival and toxicity. Head Neck 36(10):1474–1480
2. Zhang L, Chen QY, Liu H, Tang LQ, Mai HQ (2013) Emerging treatment options for nasopharyngeal carcinoma. Drug Des Dev Ther 7:37–52
3. Tham IW, Lu JJ (2010) Controversies and challenges in the current management of nasopharyngeal cancer. Expert Rev Anticancer Ther 10(9):1439–1450
4. Al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Herskovic A, Ager PJ (1990) Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol Off J Am Soc Clin Oncol 8(8):1342–1351
5. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol Off J Am Soc Clin Oncol 16(4):1310–1317
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献